Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2015 1
2016 1
2017 1
2018 5
2019 11
2020 2
2021 3
2022 7
2023 6
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Results by year

Filters applied: . Clear all
Page 1
Pan-cancer Genomic Analysis of AXL Mutations Reveals a Novel, Recurrent, Functionally Activating AXL W451C Alteration Specific to Myxofibrosarcoma.
Williams EA, Vegas I, El-Senduny FF, Zhang J, Mata DA, Hiemenz MC, Hughes SR, Sa BC, Kraft GP, Gorbatov N, Foley-Peres K, Sanchez EZ, Milikowski C, Williams KJ, Ross JS, Kurzrock R, Montgomery EA, Lombard DB, Kumar S. Williams EA, et al. Among authors: el senduny ff. Am J Surg Pathol. 2024 Feb 19. doi: 10.1097/PAS.0000000000002191. Online ahead of print. Am J Surg Pathol. 2024. PMID: 38369783
Corrigendum to "Novel spirooxindole based benzimidazole scaffold: In vitro, nanoformulation and in vivo studies on anticancer and antimetastatic activity of breast adenocarcinoma" [Bioorg. Chem. 129 (2022) 106124].
Barakat A, Alshahrani S, Al-Majid AM, Alamary AS, Haukka M, Abu-Serie MM, Dömling A, Mazyed EA, Badria FA, El-Senduny FF. Barakat A, et al. Among authors: el senduny ff. Bioorg Chem. 2024 Feb;143:107012. doi: 10.1016/j.bioorg.2023.107012. Epub 2023 Dec 8. Bioorg Chem. 2024. PMID: 38071087 No abstract available.
Retraction Note: Efficient chemosensitizing and antimetastatic combinations of a naturally occurring trans-ferulic acid with different chemotherapies on an in vitro hepatocellular carcinoma model.
Abdel-Hamid NM, ElNakeeb NA, El-Senduny FF. Abdel-Hamid NM, et al. Among authors: el senduny ff. Naunyn Schmiedebergs Arch Pharmacol. 2023 Dec;396(12):3899. doi: 10.1007/s00210-023-02774-1. Naunyn Schmiedebergs Arch Pharmacol. 2023. PMID: 37843591 No abstract available.
Efficient chemosensitizing and antimetastatic combinations of a naturally occurring trans-ferulic acid with different chemotherapies on an in vitro hepatocellular carcinoma model.
Abdel-Hamid NM, ElNakeeb NA, El-Senduny FF. Abdel-Hamid NM, et al. Among authors: el senduny ff. Naunyn Schmiedebergs Arch Pharmacol. 2023 Aug;396(8):1741-1747. doi: 10.1007/s00210-023-02431-7. Epub 2023 Feb 22. Naunyn Schmiedebergs Arch Pharmacol. 2023. PMID: 36811666 Retracted.
Novel spirooxindole based benzimidazole scaffold: In vitro, nanoformulation and in vivo studies on anticancer and antimetastatic activity of breast adenocarcinoma.
Barakat A, Alshahrani S, Mohammed Al-Majid A, Saleh Alamary A, Haukka M, Abu-Serie MM, Dömling A, Mazyed EA, Badria FA, El-Senduny FF. Barakat A, et al. Among authors: el senduny ff. Bioorg Chem. 2022 Dec;129:106124. doi: 10.1016/j.bioorg.2022.106124. Epub 2022 Sep 5. Bioorg Chem. 2022. PMID: 36174446
35 results